Suppr超能文献

Early feasibility testing and engineering development of a sutureless beating heart connector for left ventricular assist devices.

作者信息

Koenig Steven C, Jimenez Jorge H, West Seth D, Sobieski Michael A, Choi Young, Monreal Gretel, Giridharan Guruprasad A, Soucy Kevin G, Slaughter Mark S

机构信息

From the *Department of Cardiovascular and Thoracic Surgery, Cardiovascular Innovation Institute, University of Louisville, Louisville, Kentucky; †Department of Bioengineering, University of Louisville, Louisville, Kentucky; and ‡APK Advanced Medical Technologies, Atlanta, Georgia.

出版信息

ASAIO J. 2014 Nov-Dec;60(6):617-25. doi: 10.1097/MAT.0000000000000134.

Abstract

APK Advanced Medical Technologies (Atlanta, GA) is developing a sutureless beating heart (SBH) left ventricular assist device (LVAD) connector system consisting of anchoring titanium coil, titanium cannula with integrated silicone hemostatic valve, coring and delivery tool, and LVAD locking mechanism to facilitate LVAD inflow surgical procedures. Feasibility testing was completed in human cadavers (n = 4) under simulated normal and hypertensive conditions using saline to observe seal quality in degraded human tissue and assess anatomic fit; acutely in ischemic heart failure bovine model (n = 2) to investigate short-term performance and ease of use; and chronically for 30 days in healthy calves (n = 2) implanted with HeartWare HVAD to evaluate performance and biocompatibility. Complete hemostasis was achieved in human cadavers and animals at LV pressures up to 170 mm Hg. In animals, off-pump (no cardiopulmonary bypass) anchoring of the connector was accomplished in less than 1 minute with no residual bleeding after full delivery and locking of the LVAD; and implant of connector and LVAD were successfully completed in under 10 minutes with total procedure blood loss less than 100 ml. In chronic animals before necropsy, no signs of leakage or disruption at the attachment site were observed at systolic LV pressures >200 mm Hg.

摘要

相似文献

3
Atrial, ventricular, or both cannulation sites to optimize left ventricular assistance?
ASAIO J. 2001 May-Jun;47(3):261-5. doi: 10.1097/00002480-200105000-00021.
4
Thrombus on the inflow cannula of the HeartWare HVAD: an update.
Cardiovasc Pathol. 2019 Jan-Feb;38:14-20. doi: 10.1016/j.carpath.2018.09.002. Epub 2018 Sep 15.
7
Minimally invasive thoracic left ventricular assist device implantation; case series demonstrating an integrated multidisciplinary strategy.
J Cardiothorac Vasc Anesth. 2015 Apr;29(2):271-4. doi: 10.1053/j.jvca.2014.11.007. Epub 2014 Nov 11.
8
In Vitro Evaluation of Inflow Cannula Fixation Techniques in Left Ventricular Assist Device Surgery.
Artif Organs. 2017 Mar;41(3):272-275. doi: 10.1111/aor.12735. Epub 2016 Apr 18.
9
3D Morphological Changes in LV and RV During LVAD Ramp Studies.
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):159-169. doi: 10.1016/j.jcmg.2016.12.019. Epub 2017 Apr 12.
10
Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
J Thorac Cardiovasc Surg. 2014 Sep;148(3):1115-21; discussion 1021-2. doi: 10.1016/j.jtcvs.2014.05.063. Epub 2014 Jun 6.

引用本文的文献

本文引用的文献

1
Bovine model of chronic ischemic cardiomyopathy: implications for ventricular assist device research.
Artif Organs. 2013 Dec;37(12):E202-14. doi: 10.1111/aor.12129. Epub 2013 Jul 22.
2
Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
J Thorac Cardiovasc Surg. 2013 Feb;145(2):566-73; discussion 573-4. doi: 10.1016/j.jtcvs.2012.10.034. Epub 2012 Dec 13.
3
Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation.
Circulation. 2012 Jun 26;125(25):3191-200. doi: 10.1161/CIRCULATIONAHA.111.058412. Epub 2012 May 22.
4
Implantation of the HeartWare left ventricular assist device.
Semin Thorac Cardiovasc Surg. 2011 Autumn;23(3):245-7. doi: 10.1053/j.semtcvs.2011.07.008.
5
Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
Circ Heart Fail. 2012 Jan;5(1):10-6. doi: 10.1161/CIRCHEARTFAILURE.111.962951. Epub 2011 Nov 3.
6
Off-pump implantation of the HeartWare HVAD left ventricular assist device through minimally invasive incisions.
Ann Thorac Surg. 2011 Apr;91(4):1294-6. doi: 10.1016/j.athoracsur.2010.08.031.
7
Heart transplant vs left ventricular assist device in heart transplant-eligible patients.
Ann Thorac Surg. 2011 May;91(5):1330-3; discussion 1333-4. doi: 10.1016/j.athoracsur.2011.01.062. Epub 2011 Mar 24.
8
Bridge to transplantation: current outcomes.
J Card Surg. 2010 Jul;25(4):455-61. doi: 10.1111/j.1540-8191.2010.00996.x. Epub 2010 Feb 18.
9
Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.
J Heart Lung Transplant. 2010 Jan;29(1):1-10. doi: 10.1016/j.healun.2009.10.009.
10
Rise of the machines--left ventricular assist devices as permanent therapy for advanced heart failure.
N Engl J Med. 2009 Dec 3;361(23):2282-5. doi: 10.1056/NEJMe0910394. Epub 2009 Nov 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验